相关实验视频

Updated: Jan 8, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

在Uveitic Glaucoma中使用非门型玻璃眼疏通装置的长期结果

Hussain Aluzri¹, Andrew J Swampillai¹, Sami Hussain¹

¹Birmingham and Midland Eye Centre, Sandwell and West Birmingham Hospital, NHS Trust, UK.

Ophthalmology. Glaucoma

|December 18, 2025

概括

无门的玻璃眼疏通装置在10多年内为耐火性紫外线玻璃眼提供了有效的眼内压力控制. 这项研究强调了它们的长期安全性和有效性,以保护这一具有挑战性的患者群体的视力.

科学领域:

眼科医生眼科眼科
玻璃眼研究研究玻璃眼研究
管道炎管理管道炎管理

背景情况:

由于炎症和眼内压 (IOP) 升高,耐火性脑膜内光眼 (Uveitic Glaucoma) 存在重大管理挑战.
使用非膜玻璃眼排水装置 (GDD),但在这种特定患者群体中长期的结果需要进一步研究.

研究的目的:

评估非膜GDD在治疗耐火性紫外线绿内障治疗中的长期疗效和安全性.
评估眼内压力 (IOP) 控制,药物负担和延长后续期间的并发症率.

主要方法:

回顾性干预病例系列,涉及51名耐火性紫外线绿眼病患者的65只眼睛.
在2000年至2021年期间进行的Baerveldt或Molteno GDD植入,平均随访时间为12.05±4.9年.
根据世界玻璃眼协会的标准定义的手术成功;二次结果包括IOP,药物使用和并发症.

主要成果:

平均内血压从32.6mmHg显著降低到12.2mmHg (p<0.0001),而青光眼的药物从3.8降低到0.9 (p<0.0001).
合格和完全成功率分别为58.5%和33.8%,平均存活时间为12.8年和8.1年.
常见的失败原因包括下垂 (13只眼睛) 和不充分的内视压缩 (10只眼睛);最佳校正的视敏度保持稳定 (p=0.34).

结论:

非估值的GDD显示,在十多年内,在乌维性玻璃眼患者中,具有持久的IOP控制和视力保存.
该研究报告了这个队列中非膜GDD的最长的随访结果,在58.5%的眼睛中取得了合格的成功.
贝尔维尔特植入和并发的全身生物疗法是合格成功的预测因素.

关键词:

水性分流植入物植入物.青光眼的排水装置 (GDD) 是一种乌维特性玻璃眼 (Uveitic Glaucoma) 是一种疾病.排卵管炎排卵管炎是一种

更多相关视频

A Model of Glaucoma Induced by Circumlimbal Suture in Rats and Mice

A Model of Glaucoma Induced by Circumlimbal Suture in Rats and Mice

Published on: October 5, 2018

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Published on: January 26, 2018

相关概念视频

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Hemodialysis I: Introduction

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...